Merck KGaA (OTCMKTS:MKKGY – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.21), Zacks reports. Merck KGaA had a return on equity of 8.79% and a net margin of 12.07%.
Merck KGaA Stock Performance
MKKGY stock traded up $0.13 during trading hours on Thursday, hitting $33.79. 148,394 shares of the stock were exchanged, compared to its average volume of 99,302. Merck KGaA has a 12 month low of $23.73 and a 12 month high of $34.19. The company has a current ratio of 1.51, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $21.84 billion, a P/E ratio of 15.02, a P/E/G ratio of 2.98 and a beta of 0.98. The company has a 50-day simple moving average of $32.00 and a two-hundred day simple moving average of $29.19.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on MKKGY. HSBC upgraded shares of Merck KGaA to a “hold” rating in a research note on Monday, July 6th. Zacks Research raised shares of Merck KGaA from a “hold” rating to a “strong-buy” rating in a report on Wednesday, July 22nd. Finally, Jefferies Financial Group initiated coverage on shares of Merck KGaA in a research report on Tuesday, May 26th. They set a “hold” rating for the company. One research analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold”.
Merck KGaA Company Profile
Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.
Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.
Featured Articles
- Five stocks we like better than Merck KGaA
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
